Tenaya Therapeutics (TNYA) Revenue (2026)
Tenaya Therapeutics (TNYA) posted Revenue of $1.1 million for Q2 2026, up 393.33% on a QoQ basis from $225000.0 in Q1 2026.
Powered by 
Analysis
Tenaya Therapeutics (TNYA) Revenue (2026) Analysis & Trends
Tenaya Therapeutics has reported Revenue for 1 years, with the latest figure at $1.1 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.25 Bn | 9.40 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.74 Bn | 3.45 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.58 Bn | 2.62 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 490,000.00 |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.21 Bn | 1.42 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 77.46 Mn |
| 10 | Tenaya Therapeutics | 144.16 Mn | 144.16 Mn | - | 1.11 Mn |